HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
Clinical trial NCT03108664 · COMPLETED
Trial details
- NCT number
- NCT03108664
- Sponsor
- Sylentis, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-18
- Primary completion
- 2018-10-16
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.